Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04545489 · ClinicalTrials.gov registry record · NA

A Nurse-led Intervention to Extend the Veteran HIV Treatment Cascade for Cardiovascular Disease Prevention

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
305
Enrollment target

NCT04545489: Completed NA study, sponsored by VA Office of Research and Development.

NCT04545489 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 305 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04545489, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
305 participants
Enrollment target

Study Summary

The VA is the largest single provider of HIV care in the US and Veterans with HIV use significantly more healthcare services and have a 1.5-2x higher risk of atherosclerotic cardiovascular disease (ASCVD) compared to uninfected Veterans. The goal is to improve BP treatment for Veterans with HIV to reduce ASCVD risk. Within a randomized controlled trial (RCT), the investigators hypothesize that the VA adapted nurse-led intervention will result in a clinically significant 6 millimeters of mercury (mmHg) reduction in systolic blood pressure (SBP) over 12 months compared to those receiving enhanced education only. The study is innovative because of the use of stakeholder-engaged design process, multi-component nurse-led intervention, and VA Video Connect (VVC) to monitor CVD risk factors. The project meets VA strategic priorities including: 1) greater choice for Veterans; 2) improve timeliness of services; 3) focus more resources more efficiently (strengthen foundational services in VA). If shown to be effective, this intervention will have substantial impact among high-risk Veterans, potentially reducing ASCVD events by more than a quarter.

Interventions

  • BEHAVIORAL Intervention group
  • BEHAVIORAL Education control group

Trial Details

FieldValue
Enrollment Target 305 participants
Start Date 2020-12-01
Est. Completion 2025-03-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT04545489

The ClinicalTrials.gov registry entry for NCT04545489 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 305 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Intervention group is the first listed.

NCT04545489 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04545489 about?

NCT04545489 is a clinical study titled "A Nurse-led Intervention to Extend the Veteran HIV Treatment Cascade for Cardiovascular Disease Prevention". The VA is the largest single provider of HIV care in the US and Veterans with HIV use significantly more healthcare services and have a 1.5-2x higher risk of atherosclerotic cardiovascular disease (ASCVD) compared to uninfected Veterans. The goal is to improve BP treatment for Veterans with HIV to r...

What is the current status of trial NCT04545489?

This trial is currently completed. It is a NA study. The enrollment target is 305 participants. The study started on 2020-12-01. Estimated completion is 2025-03-31.

What interventions are being tested in trial NCT04545489?

The interventions under investigation include: Intervention group (BEHAVIORAL), Education control group (BEHAVIORAL).

Who is sponsoring clinical trial NCT04545489?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.